ArticleInternational journal of surgery (London, England)2026
Prognostic impact of regional lymph node excision in T3-4N+M0 gastric cancer: a retrospective cohort study on nomogram development and external validation in China.
Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Locally advanced gastric cancer, especially T3-4N + M0 cancer, has been recognized as a significant clinical challenge among all kinds of gastric cancer. Although the surgery played a crucial role in the management of T3-4N + M0 gastric cancer, the number of regional nodes excision (RNE) exerted discernible impacts on the prognosis of this type of patients. This study aims to assess the potential survival benefit associated with excision of at least 18 lymph nodes and to develop a nomogram for predicting the 5-year survival rate in T3-4N + M0 gastric cancer patients. Patients and methods: This retrospective cohort study analyzed data from patients diagnosed with T3-4N + M0 gastric cancer between 2000 and 2019 from the Surveillance, Epidemiology, and End Results (SEER) database and our cohort (1 January 2015 to 2019). Participants were divided into train and test cohorts. The intervention included RNE, with exposure groups defined by lymph node count (≥18 vs <18) and postoperative radiotherapy. Primary outcome was overall survival (OS). Statistical analyses involved LASSO regression for variable selection, Cox proportional hazards models for identifying prognostic factors, restricted cubic spline (RCS) for modeling nonlinear relationships, and evaluation of the predictive nomogram using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Results: Multivariable analysis identified ≥18 RNE and postoperative radiotherapy as independent favorable prognostic factors for OS (RNE≥18: HR = 0.47, Conclusions: This study establishes that resection of ≥18 lymph nodes and postoperative radiotherapy on those who underwent ≥18 lymph nodes significantly improves survival in T3-4N + M0 gastric cancer. We developed and validated a prognostic nomogram to guide individualized therapy. These findings advocate for standardized lymph node dissection in multimodal management, while prospective trials remain necessary to validate broader applicability. Besides, an online calculator is provided at https://yhd2314.shinyapps.io/huahuadan9_15/ to facilitate individual risk prediction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.